Technical Analysis for CARA - Cara Therapeutics, Inc.

Grade Last Price % Change Price Change
C 18.09 0.06% 0.01
CARA closed up 0.06 percent on Friday, March 5, 2021, on 1.23 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical CARA trend table...

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 0.00%
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Doji - Bullish? Reversal 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish 0.06%
Lower Bollinger Band Touch Weakness 0.06%
Oversold Stochastic Weakness 0.06%
Stochastic Buy Signal Bullish -4.44%
Older End-of-Day Signals for CARA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Lower Bollinger Band Support 2 days ago
Down 1 ATR 2 days ago
1.5x Volume Pace 2 days ago
Down 5% 2 days ago
Down 3% 2 days ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat pain. Its products include intravenous CR845 that has completed Phase II clinical trials for the treatment of acute postoperative pain in adult patients; Oral CR845, which is in Phase I clinical trials to treat acute and chronic pain; and CR701 that is in preclinical trials for treating neuropathic and inflammatory pain. The company was founded in 2004 and is based in Shelton, Connecticut.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pain Clinical Trial Chronic Pain Amines Piperidines Mesoblast Acute And Chronic Pain

Is CARA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 22.6
52 Week Low 8.88
Average Volume 518,255
200-Day Moving Average 16.21
50-Day Moving Average 18.32
20-Day Moving Average 19.62
10-Day Moving Average 19.02
Average True Range 1.08
ADX 22.11
+DI 17.16
-DI 31.40
Chandelier Exit (Long, 3 ATRs ) 19.35
Chandelier Exit (Short, 3 ATRs ) 20.02
Upper Bollinger Band 21.50
Lower Bollinger Band 17.75
Percent B (%b) 0.09
BandWidth 19.12
MACD Line -0.05
MACD Signal Line 0.27
MACD Histogram -0.3222
Fundamentals Value
Market Cap 901.46 Million
Num Shares 49.8 Million
EPS -2.17
Price-to-Earnings (P/E) Ratio -8.35
Price-to-Sales 24.99
Price-to-Book 5.73
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.15
Resistance 3 (R3) 19.93 19.04 19.80
Resistance 2 (R2) 19.04 18.51 19.14 19.69
Resistance 1 (R1) 18.56 18.19 18.80 18.78 19.57
Pivot Point 17.67 17.67 17.79 17.77 17.67
Support 1 (S1) 17.19 17.14 17.43 17.41 16.61
Support 2 (S2) 16.30 16.82 16.40 16.49
Support 3 (S3) 15.82 16.30 16.38
Support 4 (S4) 16.04